Equities

Hill Inc

HILL:CVE

Hill Inc

Actions
  • Price (CAD)0.255
  • Today's Change0.00 / 0.00%
  • Shares traded500.00
  • 1 Year change-20.31%
  • Beta0.1052
Data delayed at least 15 minutes, as of Nov 11 2024 15:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hill Incorporated is a progressive bioscience implementation company. It is engaged in building pathways to better and healthier living by leveraging its consumer-packaged goods (CPG) expertise to commercialize technologies to craft cannabis solutions and non-alcoholic beverage products globally. Its Hill Avenue Cannabis business unit is pioneering the space where craft consumer products meet bioscience by combining its CPG commercialization expertise with its rights to use Lexaria Bioscience Corp’s DehydraTECH patent portfolio for product development, licensing and business-to-business (B2B) and business-to-consumer sales of cannabis ingredients or products on a global scale. Its Hill Street Beverages business unit represents its legacy alcohol-free consumer beverage marketing and distribution business. It provides DehydraTECH-enabled B2B solutions for both cannabis extractors and ingredient suppliers and CPG manufacturers whose products are infused with cannabis and or hemp extracts.

  • Revenue in CAD (TTM)2.21m
  • Net income in CAD-1.62m
  • Incorporated2016
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aequus Pharmaceuticals Inc413.17k-2.68m663.17k12.00------1.61-0.0202-0.02020.0031-0.04690.40711.366.12---263.64-97.96---293.3153.45---647.61-141.530.0315-10.6620.49---81.53-28.977.64------
Hill Inc2.21m-1.62m837.11k----12.11--0.3792-0.4977-0.49770.6770.02110.582211.264.55---42.86-56.07-48.68-70.1660.7453.77-73.61-106.941.28-5.830.9749---23.4511.5122.89------
Lumiera Health Inc604.19k-2.41m861.63k--------1.43-0.0142-0.01420.0036-0.01390.50962.1311.78---202.92------13.17---398.18--0.0395-2.10----46.91---188.58------
Vitality Products Inc766.56k-153.51k1.04m--------1.35-0.0037-0.00370.0185-0.03450.92061.127.02---18.44-28.04----72.7973.72-20.03-42.490.1453-------4.768.3149.92---0.619--
Data as of Nov 11 2024. Currency figures normalised to Hill Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.